Cargando…
Treatment of immune thrombocytopenia in Australian adults: A multicenter retrospective observational study
BACKGROUND: In Australia, prescribing restrictions limit access to internationally recommended second‐line therapies such as rituximab and thrombopoietin agonists (TPO‐A) (eltrombopag and romiplostim). Subsequent lines of therapy include an array of immunosuppressive and immune‐modulating agents dir...
Autores principales: | Rosenberg, Adam, Cashion, Catelyn, Ali, Fariya, Haran, Harini, Biswas, Raaj K., Chen, Vivien, Crowther, Helen, Curnow, Jennifer, Deakin, Elyssa, Tan, Chee‐Wee, Tan, Yi Ling, Vanlint, Andrew, Ward, Christopher M., Bird, Robert, Rabbolini, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483174/ https://www.ncbi.nlm.nih.gov/pubmed/36186101 http://dx.doi.org/10.1002/rth2.12792 |
Ejemplares similares
-
Immune thrombocytopenia following vaccination during the COVID-19 pandemic
por: Choi, Philip Young-Ill, et al.
Publicado: (2021) -
Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia
por: Chen, Vivien M, et al.
Publicado: (2021) -
Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients
por: Choi, Philip Young-Ill, et al.
Publicado: (2022) -
Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand
por: Choi, Philip YI, et al.
Publicado: (2021) -
Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)